Skip to main content
. Author manuscript; available in PMC: 2011 Feb 18.
Published in final edited form as: Hum Vaccin. 2009 Aug 14;5(8):536–544. doi: 10.4161/hv.5.8.8725

Figure 1.

Figure 1

Anti-PA IgG responses (upper) and anti-LF IgG responses (lower) following vaccination with VCL-AB01 at Weeks 0, 4 and 8. Each line represents the longitudinal antibody levels from individual responders from all 3 dosing groups (0.2 mg, solid squares; 0.6 mg, solid circles; and 2 mg, open squares) for 6 time points up to 1 year after the first vaccination.